4/A: BIO-KEY CEO Increases Stake in Company

BIO-KEY International CEO Michael W. DePasquale reported additional common stock purchases, increasing his direct beneficial ownership to 102,775 shares.

Summary

• Michael W. DePasquale, CEO and Chairman of BIO-KEY International Inc., acquired additional shares of common stock.
• On September 15, 2025, he purchased 2,500 shares at $0.75 per share.
• On September 16, 2025, he purchased 1,617 shares at $0.84 per share.
• Following these transactions, his direct beneficial ownership of common stock increased to 102,775 shares.
• This filing is an amendment (Form 4/A) to correct previously reported holdings, specifically excluding options to purchase 232 shares and warrants for 9,167 shares that were included in an earlier Form 4.

Sentiment

Score: 7

Explanation: The CEO's purchase of additional shares indicates confidence in the company. However, the need for an amendment to correct previously reported holdings suggests a minor administrative oversight.

Positives

• CEO Michael W. DePasquale increased his direct beneficial ownership in BIO-KEY International Inc. by purchasing additional common stock, which can signal management's confidence in the company's future prospects.

Negatives

• The amendment indicates a correction was needed for a previously filed Form 4, suggesting a minor administrative oversight in the initial filing regarding derivative securities.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This filing reports an insider transaction, which is a routine disclosure. It does not provide broader industry context or trends. Insider buying can sometimes be interpreted as a positive signal of management's belief in the company's future, potentially indicating undervaluation or upcoming positive developments, but this is not explicitly stated in the filing.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4/A) and does not contain information that allows for a direct comparison to industry-specific operational or financial benchmarks. Insider buying activity is common across industries, and the significance of such purchases is often evaluated in the context of the company's specific performance and market conditions rather than against direct industry peers' insider activity.

Related Party Transactions

• Michael W. DePasquale, in his capacity as CEO and Chairman, acquired 4,117 shares of BIO-KEY International Inc. common stock through open market purchases on September 15 and 16, 2025, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: May view the CEO's increased stake as a positive signal of management confidence, potentially influencing investor sentiment.

Key Dates

Recommendation

The CEO's decision to increase his direct stake in BIO-KEY International Inc. by purchasing additional common stock is generally a positive indicator, suggesting confidence in the company's future performance. However, this Form 4/A filing is a transactional report and does not provide sufficient comprehensive financial or operational data to warrant a 'buy' or 'sell' recommendation. Investors should consider this insider activity as one data point among broader fundamental analysis before making investment decisions. The amendment to correct previously reported derivative holdings is a minor administrative detail that does not significantly alter the overall sentiment.

Keywords

BIO-KEY International, BKYI, Insider Trading, Form 4/A, Stock Purchase, CEO, Beneficial Ownership, Michael DePasquale